Indonesia grants emergency use authorization to Sinovac’s COVID-19 vaccine

JAKARTA: Indonesia’s food and drug agency on Monday granted emergency use approval to a COVID-19 vaccine developed by China’s Sinovac Biotech, as it became the first country outside China to give the regulatory greenlight to the vaccine.
Interim data from a late-stage human test in Indonesia showed the shot was 65.3% effective, Penny K. Lukito, who heads the country’s food and drugs authority BPOM said.